| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 81.927 | 39.032 | 4.788 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 81.928 | 39.069 | 4.800 | 0 | 0 | 0 | 1.796 | 0 | 0 | 0 |
| Total Expenses - EUR | 70.369 | 38.065 | 16.756 | 0 | 0 | 0 | 0 | 0 | 51 | 0 |
| Gross Profit/Loss - EUR | 11.560 | 1.004 | -11.955 | 0 | 0 | 0 | 1.796 | 0 | -51 | 0 |
| Net Profit/Loss - EUR | 8.127 | -107 | -12.086 | 0 | 0 | 0 | 1.742 | 0 | -51 | 0 |
| Employees | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Prorocarm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 3.130 | 10.411 | 224 | 220 | 215 | 211 | 0 | 0 | 0 | 0 |
| Inventories | 2.741 | 10.246 | 0 | 92 | 90 | 89 | 0 | 0 | 0 | 0 |
| Receivables | 312 | 107 | 144 | 49 | 48 | 47 | 0 | 0 | 0 | 0 |
| Cash | 77 | 58 | 80 | 78 | 77 | 75 | 0 | 0 | 0 | 0 |
| Shareholders Funds | -26.045 | -25.886 | -37.535 | -36.846 | -36.133 | -35.448 | -32.920 | -33.022 | -32.972 | -32.788 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 29.175 | 36.297 | 37.759 | 37.066 | 36.348 | 35.659 | 32.920 | 33.022 | 32.972 | 32.788 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1011 - 1011" | |||||||||
| CAEN Financial Year |
1011
|
|||||||||
Comments - Prorocarm Srl